Prudente et al. found that IRS1 Gly972Arg polymorphism was associated with failure to oral antidiabetes drugs among patients with T2DM in a large and ethnically homogeneous sample [34]. This evidence concerns the gene IRS1 and type 2 diabetes mellitus.